FDA’s olmesartan probe showed no increased CV risk in diabetes June 25, 2014HypertensionLipid DisordersDiabetes
Empagliflozin improves glycemia, blood pressure in type 2 diabetes study May 15, 2014HypertensionLipid DisordersDiabetes
One in four patients with hypertension nonadherent to therapyApril 2, 2014HypertensionLipid DisordersObesity
